Search

 

Cablegate: Japan Avian Influenza Update

VZCZCXRO9812
PP RUEHHM RUEHLN RUEHMA RUEHPB RUEHPOD
DE RUEHKO #0882 0920822
ZNR UUUUU ZZH
P 010822Z APR 08
FM AMEMBASSY TOKYO
TO RUEHC/SECSTATE WASHDC PRIORITY 3041
INFO RUEHZN/ENVIRONMENT SCIENCE AND TECHNOLOGY COLLECTIVE
RUEHJA/AMEMBASSY JAKARTA 4346
RUEHHI/AMEMBASSY HANOI 1066
RUEHBJ/AMEMBASSY BEIJING 2536
RUEHFK/AMCONSUL FUKUOKA 6994
RUEHNAG/AMCONSUL NAGOYA 5452
RUEHNH/AMCONSUL NAHA 9377
RUEHOK/AMCONSUL OSAKA KOBE 0663
RUEHKSO/AMCONSUL SAPPORO 7590
RUEHRC/USDA FAS WASHDC 8571
RUEAUSA/DEPT OF HHS WASHINGTON DC
RUEAIIA/CIA WASHDC

UNCLAS TOKYO 000882

SIPDIS

DEPT FOR AIAG AMBASSADOR LANGE
DEPT FOR OES/IHA COMELLA
DEPT FOR EAP/J
USDA PASS TO APHIS
HHS PASS TO CDC
HHS FOR OGHA STEIGER AND HICKEY
DEPT PASS TO AID/GH/HIDN DENNIS CARROLL

SIPDIS

E.O. 12958: N/A
TAGS: TBIO KFLU KSTH ECON PREL SOCI CASC JA
SUBJECT: JAPAN AVIAN INFLUENZA UPDATE

REF: A. 05 STATE 153802
B. 08 TOKYO 246 AND PREVIOUS
C. 06 TOKYO 2135

1. No human or animal outbreaks of H5N1 Avian Influenza (AI) were
reported in Japan during the period of January 30 to March 31 2008.

Japanese research team develops a new PI vaccine.
--------------------------------------------- ----

2. A Japanese research team has developed a new vaccine for
pandemic influenza, which can respond quickly to the influenza virus
despite minor modifications of DNA sequences, according to an
article in the March 12 Asahi Shimbun. Japan's Ministry of Health,
Labor and Welfare (MHLW) funded the team, consisting of researchers
from the National Institute of Infectious Diseases (NIID), Hokkaido
University, and the Research Foundation for Microbial Disease of
Osaka University. Team leader Dr. Hideki Hasegawa of NIID told ECON
LES that the team developed the nasal-spray vaccine using a H5N1
virus from a human case in Vietnam in 2004 and Ampligen as adjuvant.
Using tests on mice and monkeys, the team confirmed the vaccine is
effective for multiple H5N1 virus strains including, the Hong Kong
H5N1 strain of 1997 and the Indonesian H5N1 strain of 2005. The new
vaccine is expected to respond to a pandemic influenza developed by
modification of the H5N1 virus. The team will conduct further
animal tests for two years to confirm its safety and hopes to start
a clinical test on humans in Japanese fiscal year 2010.

SCHIEFFER

© Scoop Media

 
 
 
 
 
World Headlines

 

Werewolf: Gordon Campbell On North Korea, Neo-Nazism, And Milo

With a bit of luck the planet won’t be devastated by nuclear war in the next few days. US President Donald Trump will have begun to fixate on some other way to gratify his self-esteem – maybe by invading Venezuela or starting a war with Iran. More>>

Victory Declared: New Stabilisation Funding From NZ As Mosul Is Retaken

New Zealand has congratulated the Iraqi government on the successful liberation of Mosul from ISIS after a long and hard-fought campaign. More>>

Gordon Campbell: On The Current US Moves Against North Korea

If Martians visited early last week, they’d probably be scratching their heads as to why North Korea was being treated as a potential trigger for global conflict... More>>

ALSO:

Gordon Campbell: On The Lessons From Corbyn’s Campaign

Leaving partisan politics aside – and ignoring Jeremy Corbyn’s sensational election campaign for a moment – it has to be said that Britain is now really up shit creek... More>>

ALSO:

Another US Court: Fourth Circuit Rules Muslim Ban Discriminatory

ACLU: Step by step, point by point, the court laid out what has been clear from the start: The president promised to ban Muslims from the United States, and his executive orders are an attempt to do just that. More>>

ALSO:

 
 
 
 
 
 
  • Pacific.Scoop
  • Cafe Pacific
  • PMC